STERIS plc Other Comprehensive Income (Loss), Net of Tax
STERIS plc (STE) reported Other Comprehensive Income (Loss), Net of Tax of $181.60 million for the 12-month period ending 2026-03-31, per its 10-K filed 2026-05-29.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-05-29
- STERIS plc other comprehensive income (loss), net of tax for the quarter ending 2025-03-31 was $82.02M.
- STERIS plc other comprehensive income (loss), net of tax for the quarter ending 2024-12-31 was -$208.30M, a 254.92% decline year-over-year.
- STERIS plc other comprehensive income (loss), net of tax for the quarter ending 2024-09-30 was $157.31M.
- STERIS plc other comprehensive income (loss), net of tax for the quarter ending 2024-06-30 was $5.66M, a 44.57% decline year-over-year.
- STERIS plc other comprehensive income (loss), net of tax for fiscal 2026 was $181.60M, a 1791.67% increase from fiscal 2025.
- STERIS plc other comprehensive income (loss), net of tax for fiscal 2025 was $9.60M.
- STERIS plc other comprehensive income (loss), net of tax for fiscal 2024 was -$6.60M.
- STERIS plc other comprehensive income (loss), net of tax for fiscal 2023 was -$110.44M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month | Other Comprehensive Income (Loss), Net of Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | $181.60M 10-K · filed 2026-05-29 | ||||
| 2025-03-31 | $82.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | -$126.28M derived: sum of 2 quarters · filed 2026-05-29 | $31.03M derived: sum of 3 quarters · filed 2026-05-29 | $9.60M 10-K · filed 2026-05-29 | |
| 2024-12-31 | -$208.30M 10-Q · filed 2025-02-07 | -$50.99M derived: sum of 2 quarters · filed 2025-02-07 | -$72.42M 10-Q · filed 2025-02-07 | -$121.00M derived: sum of 4 quarters · filed 2026-05-29 | |
| 2024-09-30 | $157.31M 10-Q · filed 2024-11-07 | $135.88M 10-Q · filed 2024-11-07 | $87.31M derived: sum of 3 quarters · filed 2026-05-29 | $221.76M derived: sum of 4 quarters · filed 2026-05-29 | |
| 2024-06-30 | $5.66M 10-Q · filed 2024-08-08 | -$70.01M derived: sum of 2 quarters · filed 2026-05-29 | $64.45M derived: sum of 3 quarters · filed 2026-05-29 | -$11.15M derived: sum of 4 quarters · filed 2026-05-29 | |
| 2024-03-31 | -$75.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $58.79M derived: sum of 2 quarters · filed 2026-05-29 | -$16.81M derived: sum of 3 quarters · filed 2026-05-29 | -$6.60M 10-K · filed 2026-05-29 | -$6.60M 10-K · filed 2025-05-29 |
| 2023-12-31 | $134.46M 10-Q · filed 2025-02-07 | $58.85M derived: sum of 2 quarters · filed 2025-02-07 | $69.07M 10-Q · filed 2025-02-07 | $112.64M derived: sum of 4 quarters · filed 2025-05-29 | |
| 2023-09-30 | -$75.60M 10-Q · filed 2024-11-07 | -$65.39M 10-Q · filed 2024-11-07 | -$21.82M derived: sum of 3 quarters · filed 2025-05-29 | $212.28M derived: sum of 4 quarters · filed 2025-05-29 | |
| 2023-06-30 | $10.21M 10-Q · filed 2024-08-08 | $53.78M derived: sum of 2 quarters · filed 2025-05-29 | $287.88M derived: sum of 3 quarters · filed 2025-05-29 | $78.22M derived: sum of 4 quarters · filed 2025-05-29 | |
| 2023-03-31 | $43.57M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | $277.67M derived: sum of 2 quarters · filed 2025-05-29 | $68.01M derived: sum of 3 quarters · filed 2025-05-29 | -$110.44M 10-K · filed 2025-05-29 | |
| 2022-12-31 | $234.10M 10-Q · filed 2024-02-08 | $24.44M derived: sum of 2 quarters · filed 2024-02-08 | -$154.01M 10-Q · filed 2024-02-08 | ||
| 2022-09-30 | -$209.65M 10-Q · filed 2023-11-07 | -$388.09M 10-Q · filed 2023-11-07 | |||
| 2022-06-30 | -$178.44M 10-Q · filed 2023-08-08 | ||||
| 2021-12-31 | -$30.06M 10-Q · filed 2023-02-08 | -$97.89M derived: sum of 2 quarters · filed 2023-02-08 | -$72.36M 10-Q · filed 2023-02-08 | ||
| 2021-09-30 | -$67.82M 10-Q · filed 2022-11-09 | -$42.30M 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | $25.52M 10-Q · filed 2022-08-08 | ||||
| 2020-12-31 | $129.06M 10-Q · filed 2022-02-09 | $207.63M derived: sum of 2 quarters · filed 2022-02-09 | $235.58M 10-Q · filed 2022-02-09 | ||
| 2020-09-30 | $78.58M 10-Q · filed 2021-11-08 | $106.52M 10-Q · filed 2021-11-08 | |||
| 2020-06-30 | $27.94M 10-Q · filed 2021-08-09 | ||||
| 2019-12-31 | $77.49M 10-Q · filed 2021-02-09 | $9.32M derived: sum of 2 quarters · filed 2021-02-09 | $12.95M 10-Q · filed 2021-02-09 | ||
| 2019-09-30 | -$68.18M 10-Q · filed 2020-11-06 | -$64.55M 10-Q · filed 2020-11-06 | |||
| 2019-06-30 | $3.63M 10-Q · filed 2020-08-07 | ||||
| 2018-12-31 | -$39.68M 10-Q · filed 2020-02-10 | -$44.80M derived: sum of 2 quarters · filed 2020-02-10 | -$175.05M 10-Q · filed 2020-02-10 | ||
| 2018-09-30 | -$5.12M 10-Q · filed 2019-11-07 | -$135.37M 10-Q · filed 2019-11-07 | |||
| 2018-06-30 | -$130.25M 10-Q · filed 2019-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |